These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 21304444

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Sallee F, Connor DF, Newcorn JH.
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):308-19. PubMed ID: 23782125
    [Abstract] [Full Text] [Related]

  • 7. Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
    McGough JJ, Pataki CS, Suddath R.
    Expert Rev Neurother; 2005 Jul; 5(4):437-41. PubMed ID: 16026226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract] [Full Text] [Related]

  • 11. Optimizing ADHD therapy with sustained-release methylphenidate.
    Lawrence JD, Lawrence DB, Carson DS.
    Am Fam Physician; 1997 Apr; 55(5):1705-9, 1711-2. PubMed ID: 9105199
    [Abstract] [Full Text] [Related]

  • 12. Extended-release clonidine for sleep disorders.
    Horacek HJ.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1210. PubMed ID: 7982875
    [No Abstract] [Full Text] [Related]

  • 13. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
    Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD.
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 17. Another long-acting methylphenidate (Metadate CD).
    Med Lett Drugs Ther; 2001 Oct 01; 43(1114):83-4. PubMed ID: 11581582
    [No Abstract] [Full Text] [Related]

  • 18. Drugs for ADHD.
    Med Lett Drugs Ther; 2015 Mar 16; 57(1464):37-40. PubMed ID: 25758544
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.
    Hunt RD.
    Psychopharmacol Bull; 1987 Mar 16; 23(1):111-4. PubMed ID: 3602304
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.